Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » RBRM » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
lukin4winners  - posted
This news looks very impressive and the stock has been sold off the last couple weeks. It has no where to go but up imo:
ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
Oct 3, 2007 8:45:00 AM
CHARLES TOWN, W. Va., Oct. 3 /PRNewswire-FirstCall/ -- In advance of releasing third quarter financial data, ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) noted today that each month in 2007 has produced nearly twice the sales revenues compared to the same month in 2006 for the Company. "Production costs are drastically down and our biggest problem is having enough space for the increase in inventory required by the leap in sales," reported CEO, David B Phillips.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

ReBuilder Medical Technologies, Inc. correctly anticipated this increase in sales and a corresponding increase in equity sales during the third quarter. The company is meeting the needs of the cutting-edge treatment market for diabetic peripheral neuropathy and the special hygiene requirements of diabetics. "There are several complementary treatment modalities but none competes with the effectiveness of the ReBuilder System(R)," notes Dr. Phillips, "and our patients can tell the difference, some having gone from invalid status to recovering 100% of their pre-disease mobility in less than 90 days."

Daena Carter, the Company's CFO, points to record setting revenue on several days in September 2007, with $22,600.00, set on September 10, being the most recent. The previous record sales day was achieved just three days earlier on September 7, with approximately $22,000.00 in sales. Ms. Carter added, "We're becoming accustomed to seeing growth at this rate while we maintain quality for our customers and concurrent transparent reporting to our shareholders
 
FrankNitti  - posted
.23

Good luck on this one....I'm just going to watch... [Wink]
 
FrankNitti  - posted
up to .27. Very nice call (as usual) L4W
 
lukin4winners  - posted
Great financial news out today 10/4 this should put the pressure on shorts:
ReBuilder Medical Technologies, Inc. Increases Third Quarter Sales Projections by 75%; Anticipates Sales of $750,000
Thursday October 4, 9:00 am ET


CHARLES TOWN, W.Va., Oct. 4 /PRNewswire-FirstCall/ -- Today ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM - News) announced that it has adjusted its sales projections for the quarter ending September 30, 2007 from a 10% increase over 3rd quarter 2006 to an 85% increase.
ADVERTISEMENT


(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"By expanding our marketing efforts, we have effectively increased our sales without increasing expensive Search Engine costs," says David B. Phillips, Ph.D. CEO of ReBuilder Medical Technologies, Inc. (http://www.rebuildermedical.com). We can now afford to reach beyond consumer marketing to the trusted advisor market of physicians and clinics. This shift in market emphasis can reduce our overall advertising costs, and increase sales because the physician can demo the ReBuilder System® and train the patient in his office setting. This may also have the effect of increasing the patient's confidence in the ReBuilder System®. With our relationship with the physician firmly grounded with the ReBuilder System® we can then introduce him to our silver based diabetic personal hygiene products like SilverMouthWash(TM) and this should also increase sales."

According to the American Diabetes Association, there are over 20 million people in the US suffering with diabetes and 30% of these patients will eventually develop the pain, numbness and loss of mobility that accompany diabetic peripheral neuropathy. The overall total economic cost of diabetes is over $132 billion. One of every 10 dollars spent on health costs in America is spent on diabetes. With the graying of the baby boomers, these numbers will climb dramatically. Over the next three years, ReBuilder Medical Technologies, Inc. has targeted one percent of the diabetic market, or 43.5 million dollars.
 
Metical1  - posted
This one looks like it may make a huge move and is beginning to breakout here...Some nice news earlier...Chart below:

 -
 
lukin4winners  - posted
RBRM news out this one is so oversold it should bounce bigly soon:
ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
Tuesday October 9, 9:00 am ET


CHARLES TOWN, W.Va., Oct. 9 /PRNewswire/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM - News) today announced a contract with ETS, Inc of Albuquerque NM (http://www.etsnm.com) to manufacture an updated version of the ReBuilder System®, the Professional Model 2407. ETS is an FDA-registered contract manufacturer for electronic device companies, including electronic glucose monitors, blood pressure cuffs and microwave ovens containing voice synthesizers to assist visually impaired diabetics.
ADVERTISEMENT


(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

For the past six months, ReBuilder Medical Technologies, Inc. and ETS have been in negotiations while ETS completed its research and development of the ReBuilder System® 2407 model, implementing valuable improvements for the device. The prototype of the newer model, which features larger knobs that are easier to adjust for those suffering from neuropathy, and a third treatment modality, has been approved, and ETS has now begun production, with the first units shipped to customers within the next 10 days.

The ReBuilder System® treats peripheral neuropathy, a side effect of diabetes, and has a success rate that tops 90%. It is also beneficial in treatment of restless leg syndrome (RLS). Providing service to diabetics suffering the most advanced symptoms will increase sales by 30% and as we penetrate the RLS market, we should see sales increasing over 45% per year for the next few years. These are patients who have become accustomed to dependence on others and are thrilled to be able to treat themselves in a way that is suitable for their unique circumstances," said Dr. Phillips.
 
lukin4winners  - posted
News out this morning on this very oversold stock.
ReBuilder Medical Technologies, Inc. to Provide Physicians With Professional Version of Its Proven ReBuilder System; Sales Expected to Increase by 14%
Oct 17, 2007 9:00:00 AM
Doctors Demand Renowned ReBuilder(R) Device for In-Office Treatment of Diabetic Peripheral Neuropathy


CHARLES TOWN, W.V., Oct. 17 /PRNewswire/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) announced to its board of directors today that the company's engineering staff has completed the design of a professional, physician-use version of its ReBuilder System(R) for the treatment of diabetic peripheral neuropathy. In addition to treating this debilitating condition, the new ReBuilder System(R) model possesses diagnostic capabilities. Each time the physician uses the system, ReBuilder Medical Technologies, Inc. will receive a portion of the fee.


(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )


The Physician's 2408 model will include ReBuilder's proven electronic treatment for neuropathy, plus a non-invasive neurological evaluation capability. The 2408 model will measure the electrical activity of muscles and nerves non-invasively, thereby determining if there is nerve damage, the extent of the damage and, in some cases, its cause.


"The redesign of the ReBuilder series represents a dramatic leap forward in the treatment and evaluation of neuropathy," said Dr. David B. Phillips, ReBuilder Medical President.


"We have had wonderful consumer market acceptance of our consumer model 2406 and earlier models," reports David B. Phillips, Ph.D., CEO of ReBuilder Medical Technologies, Inc. "Many of our retail Internet customers have taken it upon themselves to show their physician this new technology, and shared with their doctors the complete resolution of their symptoms. As a result of these successes," said Phillips, "physicians have been ordering the consumer unit for use in their offices, and insisting that we develop a professional unit that offers both stronger treatment and diagnostic capabilities. We are simply responding to that request."
 
wdcisco  - posted
The one is being diluted luckin.
 
KrickleCrack  - posted
October 17, 2007

ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand
54 minutes ago - PR Newswire

Company Looks to Add Even More Space in the Future to Keep Up with Orders

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), an emerging medical device manufacturer founded by world-renowned medical device inventor David B. Phillips, Ph.D., today announced it is increasing its manufacturing space to meet growing demand of it cutting edge medical devices and products. The company recently contracted construction of another addition on its facility in Charles Town, WV. It is looking into adding even more space off site for production so it can eliminate any supply and demand issues that may arise in the near future according to Dr. David B. Phillips, President of the Company.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)

"Silver based products alone have added significantly to our sales in 2007 so production facility growth is key to keeping pace with demand," said Phillips. "In fact, although we have just recently expanded our space, we must seek to add an additional 5,000 square feet of production space to keep up with meeting demands of internet sales alone."

The company continues to aggressively pursue strategic marketing relationships with catalog companies, physician's offices, and hospitals to leverage its position in the medical device market. Some of these relationships have been key to the sales growth of ReBuilder according to Phillips. "We are extremely focused in growing sales and building our brand and will continue to do so."

About ReBuilder Medical Technologies, Inc.:

ReBuilder Medical Technologies, Inc. is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.

ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.

More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.

http://www.rebuildermedical.com
 
Homersbud  - posted
This company seriously needs to burn in hell. It already had a huge drop and company continues to dump into every pathetic PR they release.

I'm not in, but it's just awful to see this sh!t day in/day out.

Will this POS ever bounce?
 
KrickleCrack  - posted
im not in either, just postin news. Stock has done terrible today down to 0.07 now
 
Homersbud  - posted
Ya man, I kinda figured you were just posting the news. It's just unbelievable that the company continues to put out these bs PR's just so they can continue loading up their pockets.

This POS hit $1.00 already and they killed it from there. My god, how much lower do they want it to go?
 
KrickleCrack  - posted
It seems to have a good following, but unless something happens soon I wouldnt be all too surprised to see it below 0.01 in a week or two.
 
lukin4winners  - posted
RBRM seems to be breaking the pattern today hearing there is some buying starting again. Spoke to the VP of IR Daena , she said nothing internally from the company is causing this downturn she is just as perplexed as shareholders.
 
KrickleCrack  - posted
ya was up to 0.12 for a little bit, 50% up from yesterdays low, down to 0.10 now
 
lukin4winners  - posted
Let's see if we can get some continuation today. There was a 695K buy ah at .091 so the big buyers are coming back and an email newsletter from otcstockexhange is back on it. Selling doesn't seem to be over but volume is definitely indicating lots of interest. Would like to see gradual higher lows and higher highs before pullbacks.

from the newsletter this morning:
Friday, October 19th, 2007

+++++++++++++++++++++++++++++++++

RBRM - Huge day - over 3 million in volume. We traded as high as $0.12 before some late day selling. All eyes are on this one now. Today we think we can get above $0.12 to the $0.15 range.
http://finance.yahoo.com/q?s=RBRM.PK
 
lukin4winners  - posted
RBRM had some nice news today the question is was the morning gap in anticipation and will it hold a gain? When will the sellers leave?
ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment
Oct 23, 2007 10:02:00 AM
CHARLES TOWN, W.Va., Oct. 23 /PRNewswire-FirstCall/ -- After five successful years of steady growth, ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) announced today that it is celebrating five years of continued operations by shipping out its 50,000th order, and sales growth that indicates reaching 100,000 orders by the end of 2008.


(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )


"Our ReBuilder for Diabetic Peripheral Neuropathy has been a steady winner for us. Today we celebrate our 50,000th shipment. Some of these orders were for the ReBuilder electronic device, some were for the consumable support products that the patients consume, and others were for the Phillips Molluscum Treatment System(TM) and its consumables. The ReBuilder System(R) itself can stand alone, and produces 100% profit margins, however, we have offered accessories and refills on its consumables and all together, with the new customers and the returning customers who re-order their supplies, we are happy to have reached this milestone," says David B. Phillips, Ph.D. CEO of ReBuilder Medical Technologies, Inc.


"Our sales have been growing regularly and as a result of about 33% of our sales coming from referrals from happy customers, and the new marketing partners, we hope to ship an additional 50,000 orders, in the next year, and have geared production, inventory control, and general management practices accordingly. It takes new practices to cope with the sales and customer service any company is accustomed to," said David B. Phillips, Company CEO, at the end of this interview. The anticipated 50,000 shipments should take us to the next level in mass marketing.
 
lukin4winners  - posted
Interesting updates going on with RBRM including updated financials to be listed on www.pinksheets.com this week according to CEO.
Check this link from IHUB RBRM board:
http://investorshub.*********/boards/read_msg.asp?message_id=24195741
 
wdcisco  - posted
Read my other post on HOT STOCKS! This is a scam!
 
lukin4winners  - posted
Looks like the seller is gone here and if there is a short position they will have to cover. Looking for a new upward trend.
 
lpcguy  - posted
ReBuilder Medical Technologies, Inc.'s Recent Stock Price Volatility Explained
12:48p ET November 23, 2007 (PR NewsWire)

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum, today announced it has successfully concluded analysis of the recent volatility of their stock price and presented it to the Board of Directors.

It appears that several institutional and corporate investors possibly got nervous over the sub-prime housing crisis and liquidated large portions of their portfolios. "Unfortunately, our equity was included in their programmed liquidation process. As a result, many individual investors followed suit, increasing the supply of stock available to purchase and driving down the price per share," according to David Phillips, Ph.D. CEO.

Meanwhile the company continued its steady growth as evidenced by the quarterly reports published on pinksheets.com. There was no bad news whatsoever relative to the actual operations of the company. "We are in better financial shape, in better marketing shape, in better R&D shape, and in better PR shape than ever before in our company's history," says Dr. Phillips.

"We have successfully renegotiated certain aspects of our original merger terms to reduce the possibility of any remaining large corporate holders of our equities from taking profits and dumping large blocks of our stock on the market. In addition, many of these original holders of large blocks of our equities have now liquidated the majority of their shares to individual investors. We expect that these new individuals may have the best long-term interests of our company in mind. This could have the desired effect of stabilizing the stock price and thus reflect the real value of our equities," states Dr. Phillips. He concluded his statement by saying, "Because I, personally, am an insider, I cannot buy my own company's stock. However, if I could, I would sell my dog if I had to, to buy some."

Beginning on Monday, November 26, 2007, RBRM will be releasing a series of twelve news releases that will describe several new initiatives that are very exciting and will help investors have a better understanding of the company's current success and plans to expand that success in the near future.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.
 
Homersbud  - posted
Bought some at 037 and 039.

037x045 2x1 spread is horrible
 
Homersbud  - posted
045x047 1x2!
 
Homersbud  - posted
047x05!!!!!!!!!
 
Homersbud  - posted
05x053!!!!!!!!!!!!!!!
 
Homersbud  - posted
oh man, 055x057 1x1!
 
Homersbud  - posted
Here's the 1st PR. Should be more coming during the week. 053x055 1x1

ReBuilder Medical Technologies, Inc. Announces Record Sales Month
Monday November 26, 12:25 pm ET

MRSA fears increasing public awareness of Molluscum Contagiosum

CHARLES TOWN, W.V., Nov 26 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM - News) a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum today announced record breaking sales for the month of October 2007; increase is 12% above previous record which was set in September 2007.

ADVERTISEMENT
click here
"As public awareness of the dangers related to MRSA infections climb, treating Molluscum Contagiosum quickly and noninvasively has become imperative," says David Phillips, Ph.D. CEO. "Our record sales reflect our response to the needs of our customers by providing safe, effective alternatives to the burning, freezing, and cutting methods used by physicians that can create an increased risk for opportunistic infections like MRSA."

"We are seeing sales growth across all of our product lines. Our continuing innovation is placing us ahead of the curve. We will be releasing more news about our company's plans for expansion this week," says Dr. Phillips.

For more information visit: www.rebuildermedical.com and www.molluscum.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.


Source: ReBuilder Medical Technologies, Inc.
 
lukin4winners  - posted
RBRM looks like it could be on it's way to regainig it's former pps up to $1 given time.
********.com is featuring RBRM today which should get the message out to a bigger audience. As the stock price consolidates at higher level new investors should start coming in when they realize this company is for real and just a victim of dumping from initial investors. This one could be big.
 
lukin4winners  - posted
This is part of RBRMs news blitz which is scheduled for this week:
ReBuilder Medical Technologies, Inc. Hires Internet Marketing Firm to Manage Online Advertising Campaign
Nov 28, 2007 8:00:00 AM
CHARLES TOWN, W.Va, Nov. 28 / USNewswire/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum, has hired Foreman & Pike Consulting of Moorestown, NJ to maximize their advertising returns while reducing lead costs.


(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)


"Foreman & Pike are masters of internet marketing and have an extensive background in optimizing online advertising campaigns on Google, Yahoo!, MSN, and other search engines by utilizing cases studies, keyword testing, and landing page redesign among other techniques," said Dave Blankenship, Web & IT Manager for RBRM.


"Our goal is to continue our phenomenal sales growth. We plan to expand our online advertising campaign by reinvesting the savings we gain through optimization," says David Phillips, PhD. CEO of RBRM.
 
lukin4winners  - posted
RBRM said they would be issuing pr's all this week and they are keeping their word.
ReBuilder Medical Technologies, Inc. Reports Record Black Friday Sales
Nov 29, 2007 2:05:00 PM
CHARLES TOWN, W.V., Nov. 29 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum announces record breaking Black Friday sales.


(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )


"2007 Black Friday Sales were up by 400% over the same day in 2006," said Daena Carter, CFO of ReBuilder Medical Technologies, Inc., "we are continually increasing holiday sales, last year's sales were 193% over 2005. Our phenomenal sales growth is attributable to the multi-faceted approach that we have taken in our online advertising that has provided much greater visibility to our products."
 
lpcguy  - posted
Bought 3 round lots of this when it was at .86 then it just plummeted. I held on to it. Did some more DD recently.. and bought 2500 more at .035 Their 3rd quarter report is all positive. Gross Margin Ratio of 7.24% and and and Op. Profit Margin of 6.79% This is a real company with real profits. It's under valued imo.
 
lukin4winners  - posted
Great news out and more coming according to Dr.Phillips this one is a sleeper that is about to wake up. A real company with real revenues and considerable upside;
ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October
Dec 3, 2007 11:17:00 AM
CHARLES TOWN, W.Va., Dec. 3 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA announces record profits for October 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )


"Corporate profits increased by 100% over October 2006," said Daena Carter, CFO of RBRM. "Full disclosure will be released on our annual report in January 2008."


"With the expected release of several MRSA related products in our Molluscum line in the first quarter of 2008 and the expected release of a unique peripheral neuropathy diagnostic device in the second quarter of 2008; we expect to continue our pattern of growth," according to David B. Phillips, Ph.D., CEO of RBRM, and inventor of the company's unique products
 
lukin4winners  - posted
Great news out and more coming according to Dr.Phillips this one is a sleeper that is about to wake up. A real company with real revenues and considerable upside;
ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October
Dec 3, 2007 11:17:00 AM
CHARLES TOWN, W.Va., Dec. 3 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA announces record profits for October 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )


"Corporate profits increased by 100% over October 2006," said Daena Carter, CFO of RBRM. "Full disclosure will be released on our annual report in January 2008."


"With the expected release of several MRSA related products in our Molluscum line in the first quarter of 2008 and the expected release of a unique peripheral neuropathy diagnostic device in the second quarter of 2008; we expect to continue our pattern of growth," according to David B. Phillips, Ph.D., CEO of RBRM, and inventor of the company's unique products
 
Investrman  - posted
I have read many of your posts for many weeks and I to am beyond perplexed. I have had contact to rbrm corp several times seeing the price continually sit and do nothing for all of my investment into it personally.

They have a better track record than many larger cap corps right now in fact with doubled sales & earnings and increased growth each quarter and a picture book of what a truly great investment of a company is supposed to be. BUT, as I have seen many nearly 1 million buys on close go into this stock for several months, it seems there are people ganging up to short the hell out of this everytime which keeps those long term investors like us losing tons of our personal money believing in this company.

I see rbrm just like I did SPNC years ago which started OTC and today lists on Nasdaq at nearly $20.00/share and is a medical device firm as well.

I do know rbrm contacted their transfer agent too and requested NOBO reports and contacted SEC to this phenomenon too as they wanted to know why this was going on day in and day out for so long when they are actually doing very well despite many other corps. doing bad as you see in many headlines.

I do know the corp people at rbrm cannot hold their own stock so it is not them and no type of insider selling either. Every requried SEC filing is always done ahead of time too. Their products are being sought globally today too and this price should be escalating much higher on all of the news just the past 6 months alone!

I am wondering if someone tied to the traditional medical community is having it out with them, as rbrm is an alternative method and as many know, the traditional medical community is about prescribing pills upon pills upon pills to treat peoples' syptoms only with tons of side effects, and rbrm and practitioners like them do not deal that way and treat the whole problem, not just the syptom with a pill.

Again, compared to spnc, years ago the medical community fought them like they were some fluke, when today spnc's excimer laser is embraced globally and utilized from eye surgeries to other medical needs beyond the old traditional methods of the medical community.
 
lpcguy  - posted
IMO 08' will be a great year for RBRM. Like I've said before RBRM is a real company with real profits and they always do their SEC fillings on time. So this isn't your regular PS stock. Their profits are up 100% over last year. They are also going to release several MRSA related products in their Molluscum line in the first quarter of 2008 and a unique peripheral neuropathy diagnostic device in the second quarter of 2008. Growth and profits will only continue. Selling has subsided and accumulation has begun in the last few days. We won't see prices like this much longer. Once they release their 10q form for the 4th quarter this should fly.

Rebuilder Medical Technologies, Inc. Reports Doubled Profits in October '07

Rebuilder Medical Technologies, Inc. 4th Quarter Sales Exceeding Expectations
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share